The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating
Jul 1, 2023·
,
,
Yize Mao
1st Author
,Hui Xie
Co-1st Author
Min-Yi LV
Co-1st Author
,Qiuxia Yang
Zeyu Shuang
Feng GAO
Shengping Li
Co-corresponding Author
,Lina Zhu
Co-corresponding Author
,Wei Wang
Corresponding Author
·
0 min read
